Litcius/Paper detail

Incidence, Clinicopathologic Features, HER2 Fluorescence In Situ Hybridization Profile, and Oncotype DX Results of Human Epidermal Growth Factor Receptor 2-Low Breast Cancers: Experience From a Single Academic Center

Yan Hu, Dan Jones, Weiqiang Zhao, Gary Tozbikian, Robert Wesolowski, Anil V. Parwani, Zaibo Li

2023Modern Pathology15 citationsDOI

Topics & Concepts

MedicineBreast cancerImmunohistochemistryOncologyInternal medicineEstrogen receptorCohortProgesterone receptorIncidence (geometry)Fluorescence in situ hybridizationTrastuzumabCancerHuman Epidermal Growth Factor Receptor 2PathologyStage (stratigraphy)BiologyChromosomeOpticsGenePaleontologyPhysicsBiochemistryHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchBreast Cancer Treatment Studies
Incidence, Clinicopathologic Features, HER2 Fluorescence In Situ Hybridization Profile, and Oncotype DX Results of Human Epidermal Growth Factor Receptor 2-Low Breast Cancers: Experience From a Single Academic Center | Litcius